Novo Holdings A/S agreed to acquire The Ritedose Corporation from AGIC Capital, Humanwell Healthcare (Group) Co.,Ltd. (SHSE:600079) and others on January 4, 2022. Chief Executive Officer Jody Chastain, who will continue to run the company under Novo Holdings' ownership. The transaction is subject to customary closing conditions and is expected to close in the first quarter of 2022. Goodwin Procter, LLP acted as legal advisor to Novo Holdings. RBC Capital Markets, LLC acted as financial advisor to Novo Holdings.